It's typically not recommended for pregnant or breastfeeding women without specific medical advice
FAQ Allison Buttarazzi, MD Medical Reviewer Allison Buttarazzi, MD, is board-certified in internal medicine and lifestyle medicine, and is a certified health and well-being coach
When the American Public Pays Twice Critics have noted that in cases like GLP-1 therapeutics, the public ends up paying twice: first by funding the basic research, and later by paying high prices for the resulting medicine
Recognizing Lean Liver Disease in Clinical Practice Clinicians should consider metabolic liver disease in patients who present with: Normal BMI but central adiposity (increased waist circumference) Mildly elevated liver enzymes without a clear cause Dyslipidemia or insulin resistance features Fatty liver on incidental imaging Routine use of noninvasive tests such as FIB4, ELF score, or transient elastography can help stratify risk and guide hepatology referrals
To maintain progress achieved through GLP-1 agonist therapy, continuous dedication to lifestyle interventions is necessary rather than just an initial attempt at improvement